[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"physical-examination\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:physical-examination":30},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,44],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":43},"100547595","assessment-of-overall-functioning-in-patients-with-complex-health-issues-100547595",false,"NCT06410014","Assessment of Overall Functioning in Patients With Complex Health Issues","CPH-Func","Inclusion Criteria:\n\n* All patients referred by a municipality to the Department of Social Medicine at Bispebjerg and Frederiksberg Hospital for a clinical assessment (Klinisk Funktion) who provide written consent to participate.\n\nExclusion Criteria:\n\n* Insufficient ability to communicate either in written or oral Danish","ALL","18 Years",{"count":19,"type":20},100,"ESTIMATED","OBSERVATIONAL","The overall aim of the study is to assess whether each outcome measures the same aspect of overall functioning or contributes with different aspects. More specifically, the aim of this study is to investigate the correlation between each single instrument.\n\nDuring study period all patients presenting at our clinic will be offered to participate in the study. Patients will be included in the study when referred to the department of Social Medicine and providing written informed consent to participate in the study. Inclusion will continue until 100 patients have completed an AMPS test. All participants will, apart from standard procedure, be asked to complete:\n\n* An AMPS-test\n* ADL-Q (Questionnaire concerning Activities of Daily Living)\n* ADL-I (Interview based questionnaire concerning Activites of Daily Living)\n\nAs standard procedure all participants will also perform\u002Fcomplete:\n\n* 30 seconds chair stand test (30sCST)\n* Hand grip strength (HGS)\n* Evaluation of ambulation (Cumulated Ambulation Score \u002FCAS)\n* WORQ (Work Rehabilitation Questionnaire)\n\nTo obtain the aim of the study correlation-analysis will be performed to investigate the relationship between each included instruments.",[24,25,26,27,28,29,30],"Activities of Daily Living","Surveys and Questionnaires","ADL Motor Skills","Disability Evaluation","Health Status","Muscle Strength","Physical Examination","RECRUITING","2024-12-06",{"date":34,"type":35},"2024-12-09","ACTUAL",{"date":37,"type":35},"2023-10-10",{"date":39,"type":20},"2025-02-01",{"name":41,"class":42},"University Hospital Bispebjerg and Frederiksberg","OTHER",1,{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":4,"eligibilityCriteria":50,"healthyVolunteers":51,"sex":16,"minAge":52,"maxAge":53,"enrollmentInfo":54,"targetDuration":4,"studyType":56,"phases":57,"briefSummary":59,"conditions":60,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":43},"100566263","phase-2-study-on-the-safety-and-efficacy-of-sodium-phosphate-powder-for-intestinal-preparation-in-people-aged-50-to-70-years-old-100566263","NCT06652906","Study on the Safety and Efficacy of Sodium Phosphate Powder for Intestinal Preparation in People Aged 50 to 70 Years Old","A Prospective, Multicenter, Randomized Controlled Clinical Trial on the Safety and Efficacy of Sodium Phosphate Powder for Intestinal Preparation in the Population Aged 50 to 70 Years Old","Inclusion Criteria:\n\n1. Age 50 to 70 years old, gender unlimited\n2. No contraindications for colonoscopy examination, planned to undergo colonoscopy examination in the near future\n3. Agree to participate in this study\n\nExclusion Criteria:\n\n1. Patients with a history of colorectal surgery (resection of malignant tumors, resection of rectal perforation, etc.)\n2. Electrolyte disorders and hemodialysis patients\n3. Patients with active lower gastrointestinal bleeding\n4. Patients with abnormal coagulation function\n5. Concomitant severe primary diseases such as lung, liver, kidney, and hematopoietic system, liver function ALT AST exceeds the upper limit of the reference value by 1.5 times, or Cr exceeds the upper limit of the reference value\n6. Merge other diseases that may affect the efficacy judgment or pose a significant risk, such as acute inflammatory bowel disease, colon cancer, intussusception, volvulus, intestinal obstruction, peritonitis, ascites, stubborn constipation, etc\n7. Patients with mental illness and severe neurosis\n8. Patients known to have allergies to the investigational or control drugs\n9. Participated in other clinical researchers within one month\n10. Researchers believe that there are other situations that are not suitable for inclusion, and patients are unwilling to be included in the study",true,"50 Years","70 Years",{"count":55,"type":20},8,"INTERVENTIONAL",[58],"PHASE2","Project Name: Safety and Efficacy of Sodium Phosphate Powder for Intestinal Preparation in People Aged 50 to 70: A Prospective, Multicenter, Randomized Controlled Clinical Trial The main purpose of the study is to investigate the effectiveness and safety of sodium phosphate powder for intestinal preparation in people aged 50 to 70.\n\nSecondary objective: To study the tolerance of sodium phosphate powder for intestinal preparation in the population aged 50 to 70 years and its impact on The impact of lesion detection. A prospective multicenter intervention randomized controlled clinical study of research design The total number of cases is 362 in the group leader center, with a total of 8 participating centers each having 44 cases.\n\nTreatment plan: Sodium phosphate powder group or Fujingqing group\n\nMain efficacy evaluation indicators:\n\nThe effective rate of intestinal preparation, that is, the endoscopist determines that the patient's Boston intestinal preparation score is ≥ 6 points and The ratio of patients with a bowel preparation score of ≥ 2 points per segment to the total number of patients.\n\nSafety evaluation indicators Adverse reaction incidence rate Statistical methods: Numerical variables are described using mean ± standard deviation (Mean ± SD) and estimated using normal distribution method\n\nAnalysis of main efficacy indicators:\n\nBased on the intention to treat set, including all qualified patients undergoing colonoscopy, efficacy evaluation will be conducted, Use chi square test or Fisher's exact probability method for inter group comparison. The inspection level is 0.05.\n\nResearch period from April 2023 to August 2024",[30],"2024-10-20",{"date":63,"type":35},"2024-10-22",{"date":65,"type":35},"2024-06-11",{"date":67,"type":20},"2024-12-01",{"name":69,"class":42},"RenJi Hospital"]